Hello!

I pushed Gilead Sciences to pursue development of GS-441524. This led them to develop an oral prodrug called obeldesivir (GS-5245), which is in phase 3 for outpatient COVID-19 treatment. That’s how I first got into this detective work :)

Here, I will share my opinions on the structures of various undisclosed clinical candidates across therapeutic areas. How I pick what to look into is random, but generally follows these 3 guidelines:

1.Small molecule

2.Publicly traded company (preferably)

3.In phase 1 or father (preferably)

Like my work here? I take requests for specific, heavy-lift projects. Send me a note! » molecular.sherlock@gmail.com «

Stay in the loop!

Subscribe to get full access to the newsletter and website. Every new edition of the newsletter goes directly to your inbox.

I do this for free because I think it’s fun! If you want to say thanks, consider becoming a paid subscriber! It will help cover my daily coffee habit.

Thanks for stopping by :)